A proposed clinical test for monitoring fluoropyrimidine therapy: Detection and stability of thymidylate synthase ternary complexes
暂无分享,去创建一个
R. Hruban | S. Kern | M. Canto | R. Schulick | P. Kulesza | J. Brody | T. Hucl | E. Gallmeier | K. Yoshimura
[1] A. Jimeno,et al. C-fos assessment as a marker of anti-epidermal growth factor receptor effect. , 2006, Cancer research.
[2] D. Aust,et al. Immunohistochemical Analysis of Thymidylate Synthase, Thymidine Phosphorylase, and Dihydropyrimidine Dehydrogenase in Rectal Cancer (cUICC II/III): Correlation With Histopathologic Tumor Regression After 5-Fluorouracil-Based Long-Term Neoadjuvant Chemoradiotherapy , 2005, The American journal of surgical pathology.
[3] W. Gmeiner,et al. Novel chemical strategies for thymidylate synthase inhibition. , 2005, Current medicinal chemistry.
[4] Ph.D Jackie Walling MBChB. From methotrexate to pemetrexed and beyond. A review of the pharmacodynamic and clinical properties of antifolates , 2005, Investigational New Drugs.
[5] B. Vincenzi,et al. Thymidylate Synthase Expression in Normal Colonic Mucosa: A Predictive Marker of Toxicity in Colorectal Cancer Patients Receiving 5-Fluorouracil-Based Adjuvant Chemotherapy , 2004, Oncology.
[6] S. Yoshida,et al. Expression of thymidylate synthase, thymidine phosphorylase, dihydropyrimidine dehydrogenase, E2F-1, Bak, Bcl-X, and Bcl-2, and clinical outcomes for gastric cancer patients treated with bolus 5-fluorouracil. , 2004, Oncology reports.
[7] B. Dolnick,et al. Detection of thymidylate synthase modulators by a novel screening assay. , 2003, Molecular pharmacology.
[8] C. Tournigand,et al. Pemetrexed disodium combined with oxaliplatin, SN38, or 5-fluorouracil, based on the quantitation of drug interactions in human HT29 colon cancer cells. , 2002, International journal of oncology.
[9] A. Fujioka,et al. Thymidylate synthase (TS) and ribonucleotide reductase (RNR) may be involved in acquired resistance to 5-fluorouracil (5-FU) in human cancer xenografts in vivo. , 2001, European journal of cancer.
[10] P. Johnston,et al. Immunological quantitation of thymidylate synthase‐FdUMP‐5,10‐methylenetetrahydrofolate ternary complex with the monoclonal antibody TS 106 , 1993, Anti-cancer drugs.
[11] P. Johnston,et al. Regulation of thymidylate synthase in human colon cancer cells treated with 5-fluorouracil and interferon-gamma. , 1993, Advances in experimental medicine and biology.
[12] J. Bertino,et al. Karnofsky memorial lecture. Ode to methotrexate. , 1993, Journal of Clinical Oncology.
[13] P. Johnston,et al. Production and characterization of monoclonal antibodies that localize human thymidylate synthase in the cytoplasm of human cells and tissue. , 1991, Cancer research.
[14] W. Hryniuk,et al. Dose intensity and lymphoma. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] J. Bertino. Modulation of fluorouracil by methotrexate. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] S. Steinberg,et al. Fluorouracil and high-dose leucovorin in previously treated patients with metastatic breast cancer. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] J. Bertino,et al. Sequence-dependent enhancement of HCT-8 cell kill by trimetrexate and fluoropyrimidines: implications for the mechanism of this interaction. , 1989, European Journal of Cancer and Clinical Oncology.
[18] P. Houghton,et al. Effect of polyglutamylation of 5,10-methylenetetrahydrofolate on the binding of 5-fluoro-2'-deoxyuridylate to thymidylate synthase purified from a human colon adenocarcinoma xenograft. , 1989, Biochemical pharmacology.
[19] L. Bernstein,et al. Mechanisms of innate resistance to thymidylate synthase inhibition after 5-fluorouracil. , 1988, Cancer research.
[20] B. Leyland-Jones,et al. Biochemical modulation: application of laboratory models to the clinic. , 1986, Cancer treatment reports.
[21] L. Bernstein,et al. Thymidylate synthetase inhibition in malignant tumors and normal liver of patients given intravenous 5-fluorouracil. , 1984, Cancer research.
[22] J. Bertino,et al. Sequential methotrexate and 5-fluorouracil: mechanisms of synergy. , 1983, Seminars in oncology.
[23] C. Heidelberger,et al. In vivo kinetics of thymidylate synthetase inhibition of 5-fluorouracil-sensitive and -resistant murine colon adenocarcinomas. , 1982, Cancer research.
[24] C. Benz,et al. The influence of methotrexate pretreatment on 5-fluorouracil metabolism in L1210 cells. , 1981, The Journal of biological chemistry.
[25] J. Bertino,et al. 5-fluorouracil-methotrexate synergy: enhancement of 5-fluorodeoxyridylate binding to thymidylate synthase by dihydropteroylpolyglutamates. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[26] R. Heimer,et al. Enhanced 5-fluorouracil nucleotide formation after methotrexate administration: explanation for drug synergism. , 1979, Science.
[27] C. Heidelberger,et al. Biochemical determinants of tumor sensitivity to 5-fluorouracil: ultrasensitive methods for the determination of 5-fluoro-2'-deoxyuridylate, 2'-deoxyuridylate, and thymidylate synthetase. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[28] Y. Cheng,et al. Human thymidylate synthetase. II. Derivatives of pteroylmono- and -polyglutamates as substrates and inhibitors. , 1978, The Journal of biological chemistry.
[29] D. Santi,et al. Cytotoxicity of 5-fluoro-2'-deoxyuridine: requirement for reduced folate cofactors and antagonism by methotrexate. , 1978, Proceedings of the National Academy of Sciences of the United States of America.
[30] J. White,et al. A basis for fluoropyrimidine-induced antagonism to methotrexate in Ehrlich ascites tumor cells in vitro. , 1978, Cancer research.
[31] J. Bertino,et al. Schedule-dependent antitumor effects of methotrexate and 5-fluorouracil. , 1977, Cancer research.
[32] B. Chabner,et al. Biochemical determinants of 5-fluorouracil response in vivo. The role of deoxyuridylate pool expansion. , 1975, The Journal of clinical investigation.
[33] C. Heidelberger,et al. Structures of reversible and irreversible complexes of thymidylate synthetase and fluorinated pyrimidine nucleotides. , 1974, Biochemistry.
[34] D. Santi,et al. Mechanism of interaction of thymidylate synthetase with 5-fluorodeoxyuridylate. , 1974, Biochemistry.
[35] C. Heidelberger,et al. Thymidylate synthetase: mechanism of inhibition by 5-fluoro-2'-deoxyuridylate. , 1972, Biochemical and biophysical research communications.
[36] D. Santi,et al. 5-Fluoro-2'-deoxyuridylate: covalent complex with thymidylate synthetase. , 1972, Proceedings of the National Academy of Sciences of the United States of America.
[37] P. Reyes. The synthesis of 5-fluorouridine 5'-phosphate by a pyrimidine phosphoribosyltransferase of mammalian origin. I. Some properties of the enzyme from P1534J mouse leukemic cells. , 1969, Biochemistry.